Screener
Gyre Therapeutics, Inc. GYRE Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s net income?
- Gyre Therapeutics, Inc. (GYRE) reported net income of -$22.99M in Q2 2026.
- What is the long-term trend for Gyre Therapeutics, Inc.'s net income?
- Over 3 years (2021 to 2024), Gyre Therapeutics, Inc.'s net income has grown at a -41.2% compound annual growth rate (CAGR), from -$87.93M to $17.9M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Gyre Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude